 Antony Waste Handling Cell Ltd Q2 FY2026 consolidated net profit down QoQ to Rs. 13.65 crores
Antony Waste Handling Cell Ltd Q2 FY2026 consolidated net profit down QoQ to Rs. 13.65 crores Eiko Lifesciences Ltd Q2FY26 consolidated PAT increases to Rs. 1.07 crore
Eiko Lifesciences Ltd Q2FY26 consolidated PAT increases to Rs. 1.07 crore LG Balakrishnan and Bros Ltd Q2 FY2026 consolidated net profit soars to Rs. 93.62 crores
LG Balakrishnan and Bros Ltd Q2 FY2026 consolidated net profit soars to Rs. 93.62 crores Mahindra Holidays and Resorts India Ltd posts higher consolidated PAT of Rs. 17.85 crores in Q2FY26
Mahindra Holidays and Resorts India Ltd posts higher consolidated PAT of Rs. 17.85 crores in Q2FY26 Balkrishna Industries Ltd consolidated Q2FY26 PAT falls to Rs. 273.19 crores
Balkrishna Industries Ltd consolidated Q2FY26 PAT falls to Rs. 273.19 crores 
              GLENMARK PHARMACEUTICALS LTD.'s Promoter & Director, GLENN SALDANHA has purchased 16075 equity shares of the company through Market Purchase in NSE. The shares were bought for a total amount of Rs. 10011042.
With this acquisition, the shareholding of GLENN SALDANHA has increased from 830423 (0.29%) to 846498 (0.3%). The shares were acquired during the period 12/3/2018 to 12/3/2018.
| Promoter Entity | Shares Acquired / Sold | Date / Period | Holding - Pre Transaction | Holding - Post Transaction | 
| GLENN SALDANHA | 14179 | 12/3/2018 to 12/3/2018 | 830423 (0.29%) | 844602 (0.3%) | 
| GLENN SALDANHA | 1896 | 12/3/2018 to 12/3/2018 | 844602 (0.3%) | 846498 (0.3%) |